Patterns of utilization of antihypertensive drug combinations in Bahrain: Do they conform with international guidelines?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 12, 2000, Pages 568-580

  Jassim Al Khaja, K A ^a   Sequeira, R P ^a   Mathur, V S ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Antihypertensive combinations; Prescription analysis; Primary care; Rational therapy

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRISERIN; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDRALAZINE; INDAPAMIDE; LISINOPRIL; METHYLDOPA; METOPROLOL; NIFEDIPINE; PERINDOPRIL; PROPRANOLOL; TRIAMTERENE; VERAPAMIL;

ADULT; ARTICLE; BAHRAIN; DRUG MIXTURE; DRUG UTILIZATION; FEMALE; HUMAN; HYPERTENSION; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; SEX DIFFERENCE;

EID: 0033645932     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp38568     Document Type: Article

References (50)

1. Mortality and morbidity results from the European Working Party on High Blood Pressure in the elderly trial
2. The Australian therapeutic trial on mild hypertension: Report by the Management Committee
3. Antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential renal, renovascular and malignant hypertension
4. Essential hypertension
5. The place of combination therapy in the treatment of hypertension in 1993
6. Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure
7. Blood pressure, stroke and coronary heart disease - Part 2; short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
8. Randomized trial of treatment of hypertension in elderly patients in primary care
9. Sexual symptoms in hypertensive patients: A clinical trial of antihypertensive medications
10. Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy
11. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)
12. Once daily dosing with atenolol in patients with mild or moderate hypertension
13. Guidelines for the management of Hypertension
14. Lisinopril combined with atenolol in the treatment of hypertension
15. The benefits of lowering elevated blood pressure: A critical review of studies of cardiovascular morbidity and mortality in hypertension
16. What are we really achieving with long-term antihypertensive drug therapy?
17. Antihypertensive effect of felodipine or hydralazine when added to beta- +blocker therapy
18. Angiotensin-converting enzyme inhibitors in the treatment of essential hypertension
19. Combination therapy in the treatment of hypertension
20. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomized trial
21. Five-year finding of the Hypertension, Detection and Follow-up Programme. Reduction in mortality of Persons with high-blood pressure including mild hypertension
22. Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension
23. Atenolol dose-finding studies
24. A multicentre evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension
25. Atenolol once-daily in hypertension
26. The report on detection, evaluation and treatment of high blood pressure
27. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V)
28. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI)
29. A prescription survey in a hospital hypertension outpatient clinic
30. Drug treatment: Present and future
31. Low-dose combination antihypertensive therapy: Additional efficacy without additional adverse effects?
32. Antihypertensive treatment: Past, present and future
33. Hypertension
34. Medical Research Council Trial on Treatment of Mild Hypertension: Principal results
35. Medical Research Council Trial on Treatment of Hypertension in Older Adults: Principal results
36. Therapy of moderate hypertension with calcium antagonist nitrendipine in combination with beta-receptor-blocker or diuretic
37. Dose and duration of response to β-blockers in the treatment of hypertension
38. British Hypertension Society guidelines for hypertension management: Summary
39. Angiotensin-converting enzyme inhibitors
40. Captopril at 50 mg as at 100 mg once a day reduces blood pressure for up to 24 hours: A double-blind-randomized crossover study in mild-to-moderate hypertension
41. Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society
42. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
43. Efficacy and reduced metabolic sideefects of a 15 mg chlorthalidone formulation in the treatment of hypertension
44. Captopril: Evaluation of low doses, twice daily doses and the addition of diuretics for the treatment of mild-to-moderate hypertension
45. Drug treatment for hypertension in Finnish primary health care
46. Atenolol, methyldopa, and chlorthalidone in moderate hypertension
47. Angiotensin-converting enzyme inhibitors: More different than alike? Focus on cardiac performance